| Zugriffe | |
|---|---|
| Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109) | 133 |
| Juli 2025 | August 2025 | September 2025 | Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | |
|---|---|---|---|---|---|---|---|
| Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109) | 3 | 0 | 11 | 19 | 11 | 2 | 0 |
| Zugriffe | |
|---|---|
| 2020_Kurreck_etal.pdf | 60 |
